These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26729788)

  • 1. Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions.
    Welch DR
    Cancer Res; 2016 Jan; 76(1):4-6. PubMed ID: 26729788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial Heterogeneity in the Tumor Microenvironment.
    Yuan Y
    Cold Spring Harb Perspect Med; 2016 Aug; 6(8):. PubMed ID: 27481837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of Extracellular Vesicle Transfer on Cellular Heterogeneity in Cancer: What Are the Potential Clinical Ramifications?
    Zomer A; van Rheenen J
    Cancer Res; 2016 Apr; 76(8):2071-5. PubMed ID: 27032418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes.
    McQuerry JA; Chang JT; Bowtell DDL; Cohen A; Bild AH
    J Mol Med (Berl); 2017 Nov; 95(11):1167-1178. PubMed ID: 28871446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment.
    Mangano A; Lianos GD; Mangano A; Boni L; Dionigi G
    Future Oncol; 2015; 11(4):561-4. PubMed ID: 25686113
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug resistance, epigenetics, and tumor cell heterogeneity.
    Hoey T
    Sci Transl Med; 2010 Apr; 2(28):28ps19. PubMed ID: 20410528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism for asymmetric cell division resulting in proliferative asynchronicity.
    Dey-Guha I; Alves CP; Yeh AC; Salony ; Sole X; Darp R; Ramaswamy S
    Mol Cancer Res; 2015 Feb; 13(2):223-30. PubMed ID: 25582703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint.
    Rueff J; Rodrigues AS
    Methods Mol Biol; 2016; 1395():1-18. PubMed ID: 26910065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Models of oncogenesis: an endless world?].
    Larsen CJ
    Bull Cancer; 2013 Jun; 100(6):555-60. PubMed ID: 23719507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathobiology of pancreatic cancer: implications on therapy.
    Regel I; Hausmann S; Benitz S; Esposito I; Kleeff J
    Expert Rev Anticancer Ther; 2016; 16(2):219-27. PubMed ID: 26652651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell sorting in cancer research--diminishing degree of cell heterogeneity.
    Barteneva NS; Ketman K; Fasler-Kan E; Potashnikova D; Vorobjev IA
    Biochim Biophys Acta; 2013 Aug; 1836(1):105-22. PubMed ID: 23481260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Single-cell sequencing and tumour heterogeneity].
    Jordan B
    Med Sci (Paris); 2014 Dec; 30(12):1184-6. PubMed ID: 25537050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward understanding and exploiting tumor heterogeneity.
    Alizadeh AA; Aranda V; Bardelli A; Blanpain C; Bock C; Borowski C; Caldas C; Califano A; Doherty M; Elsner M; Esteller M; Fitzgerald R; Korbel JO; Lichter P; Mason CE; Navin N; Pe'er D; Polyak K; Roberts CW; Siu L; Snyder A; Stower H; Swanton C; Verhaak RG; Zenklusen JC; Zuber J; Zucman-Rossi J
    Nat Med; 2015 Aug; 21(8):846-53. PubMed ID: 26248267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stochastic phenomena and the tumoral process].
    Capp JP
    Med Sci (Paris); 2014; 30(6-7):693-8. PubMed ID: 25014464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy.
    Koren S; Bentires-Alj M
    Mol Cell; 2015 Nov; 60(4):537-46. PubMed ID: 26590713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells in tumor heterogeneity.
    Pietras A
    Adv Cancer Res; 2011; 112():255-81. PubMed ID: 21925307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineering.
    Yang KR; Mooney SM; Zarif JC; Coffey DS; Taichman RS; Pienta KJ
    J Cell Biochem; 2014 Sep; 115(9):1478-85. PubMed ID: 24700698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and phenotypic heterogeneity of human malignancies: finding order in chaos.
    Shackney SE; Shankey TV
    Cytometry; 1995 Sep; 21(1):2-5. PubMed ID: 8529466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.